# EVgo Inc.: financial statements, quarterly

EVGO · Nasdaq · CIK 1821159 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evgo.md) · [Financials](/companies/evgo/financials.md) · [Filings](/companies/evgo/filings.md) · [Insiders](/companies/evgo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/evgo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [35.1](/filings/0001558370-24-015319.md) | [50.0 d](/filings/0001558370-25-002400.md) | [55.2](/filings/0001558370-25-006523.md) | [66.6](/filings/0001558370-25-010333.md) | [67.5](/filings/0001104659-25-109155.md) | [67.5 d](/filings/0001104659-26-024827.md) | [75.3](/filings/0001821159-26-000010.md) | [98.0](/filings/0001821159-26-000019.md) | [92.3](/filings/0001104659-25-109155.md) | [118 d](/filings/0001104659-26-024827.md) | [110](/filings/0001821159-26-000010.md) | [82.6](/filings/0001821159-26-000019.md) |
| Cost of revenue | $m | [34.5](/filings/0001558370-24-015319.md) | [46.5 d](/filings/0001558370-25-002400.md) | [48.3](/filings/0001558370-25-006523.md) | [60.2](/filings/0001558370-25-010333.md) | [61.2](/filings/0001104659-25-109155.md) | [57.8 d](/filings/0001104659-26-024827.md) | [66.0](/filings/0001821159-26-000010.md) | [84.1](/filings/0001821159-26-000019.md) | [79.7](/filings/0001104659-25-109155.md) | [73.5 d](/filings/0001104659-26-024827.md) | [96.6](/filings/0001821159-26-000010.md) | [75.3](/filings/0001821159-26-000019.md) |
| Gross profit | $m | [0.6](/filings/0001558370-24-015319.md) | [3.5 d](/filings/0001558370-25-002400.md) | [6.8](/filings/0001558370-25-006523.md) | [6.4](/filings/0001558370-25-010333.md) | [6.4](/filings/0001104659-25-109155.md) | [9.8 d](/filings/0001104659-26-024827.md) | [9.3](/filings/0001821159-26-000010.md) | [13.9](/filings/0001821159-26-000019.md) | [12.6](/filings/0001104659-25-109155.md) | [45.0 d](/filings/0001104659-26-024827.md) | [13.0](/filings/0001821159-26-000010.md) | [7.3](/filings/0001821159-26-000019.md) |
| Selling, general and administrative | $m | not reported | not reported | [34.2](/filings/0001558370-25-006523.md) | [33.8](/filings/0001558370-25-010333.md) | [33.1](/filings/0001104659-25-109155.md) | not reported | [38.6](/filings/0001558370-25-006523.md) | [40.6](/filings/0001558370-25-010333.md) | [43.4](/filings/0001104659-25-109155.md) | not reported | not reported | not reported |
| Operating income | $m | [(36.4)](/filings/0001558370-24-015319.md) | [(40.8) d](/filings/0001558370-25-002400.md) | [(32.4)](/filings/0001558370-25-006523.md) | [(32.4)](/filings/0001558370-25-010333.md) | [(31.8)](/filings/0001104659-25-109155.md) | [(35.0) d](/filings/0001104659-26-024827.md) | [(33.4)](/filings/0001821159-26-000010.md) | [(30.8)](/filings/0001821159-26-000019.md) | [(34.1)](/filings/0001104659-25-109155.md) | [(12.4) d](/filings/0001104659-26-024827.md) | [(36.3)](/filings/0001821159-26-000010.md) | [(40.1)](/filings/0001821159-26-000019.md) |
| Interest expense | $m | not reported | not reported | [0.0](/filings/0001558370-25-006523.md) | [0.0](/filings/0001558370-25-010333.md) | [0.0](/filings/0001104659-25-109155.md) | [0.1 d](/filings/0001104659-26-024827.md) | [0.5](/filings/0001821159-26-000010.md) | [0.9](/filings/0001821159-26-000019.md) | [1.9](/filings/0001104659-25-109155.md) | [2.8 d](/filings/0001104659-26-024827.md) | [3.0](/filings/0001821159-26-000010.md) | [8.2](/filings/0001821159-26-000019.md) |
| Income tax | $m | [0.0 d](/filings/0001558370-24-015319.md) | [0.0 d](/filings/0001558370-25-002400.md) | [0.0](/filings/0001558370-25-006523.md) | [0.1](/filings/0001558370-25-010333.md) | [0.0](/filings/0001104659-25-109155.md) | [(2.4) d](/filings/0001104659-26-024827.md) | [0.1](/filings/0001821159-26-000010.md) | [0.0](/filings/0001821159-26-000019.md) | [(5.2)](/filings/0001104659-25-109155.md) | [(0.0) d](/filings/0001104659-26-024827.md) | [0.0](/filings/0001821159-26-000010.md) | [(0.3)](/filings/0001821159-26-000019.md) |
| Net income | $m | [(9.7)](/filings/0001558370-24-015319.md) | [(12.6) d](/filings/0001558370-25-002400.md) | [(9.8)](/filings/0001104659-25-109155.md) | [(10.4)](/filings/0001104659-25-109155.md) | [(11.7)](/filings/0001104659-25-109155.md) | [(12.4) d](/filings/0001104659-26-024827.md) | [(11.4)](/filings/0001821159-26-000019.md) | [(13.0)](/filings/0001821159-26-000019.md) | [(12.4)](/filings/0001104659-25-109155.md) | [(4.8) d](/filings/0001104659-26-024827.md) | [(16.4)](/filings/0001821159-26-000019.md) | [(20.8)](/filings/0001821159-26-000019.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001558370-24-015319.md) | not reported | [(0.09)](/filings/0001558370-25-006523.md) | [(0.10)](/filings/0001558370-25-010333.md) | [(0.11)](/filings/0001104659-25-109155.md) | not reported | [(0.09)](/filings/0001821159-26-000010.md) | [(0.10)](/filings/0001821159-26-000019.md) | [(0.09)](/filings/0001104659-25-109155.md) | not reported | [(0.12)](/filings/0001821159-26-000010.md) | [(0.15)](/filings/0001821159-26-000019.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001558370-24-015319.md) | not reported | [(0.09)](/filings/0001558370-25-006523.md) | [(0.10)](/filings/0001558370-25-010333.md) | [(0.11)](/filings/0001104659-25-109155.md) | not reported | [(0.09)](/filings/0001821159-26-000010.md) | [(0.10)](/filings/0001821159-26-000019.md) | [(0.09)](/filings/0001104659-25-109155.md) | not reported | [(0.12)](/filings/0001821159-26-000010.md) | [(0.15)](/filings/0001821159-26-000019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [209](/filings/0001104659-26-024827.md) | [175](/filings/0001558370-25-006523.md) | [162](/filings/0001558370-25-010333.md) | [142](/filings/0001104659-25-109155.md) | [117](/filings/0001821159-26-000019.md) | [150](/filings/0001821159-26-000010.md) | [154](/filings/0001821159-26-000019.md) | [181](/filings/0001104659-25-109155.md) | [151](/filings/0001821159-26-000019.md) | [122](/filings/0001821159-26-000010.md) | [122](/filings/0001821159-26-000019.md) |
| Current assets | $m | [278](/filings/0001558370-23-018279.md) | [267](/filings/0001558370-25-002400.md) | [239](/filings/0001558370-24-007044.md) | [225](/filings/0001558370-24-010606.md) | [224](/filings/0001558370-24-015319.md) | [205](/filings/0001104659-26-024827.md) | [251](/filings/0001558370-25-006523.md) | [252](/filings/0001558370-25-010333.md) | [285](/filings/0001104659-25-109155.md) | [296](/filings/0001821159-26-000019.md) | [239](/filings/0001821159-26-000010.md) | [273](/filings/0001821159-26-000019.md) |
| Total assets | $m | [817](/filings/0001558370-23-018279.md) | [807](/filings/0001558370-25-002400.md) | [788](/filings/0001558370-24-007044.md) | [785](/filings/0001558370-24-010606.md) | [792](/filings/0001558370-24-015319.md) | [804](/filings/0001104659-26-024827.md) | [856](/filings/0001558370-25-006523.md) | [865](/filings/0001558370-25-010333.md) | [932](/filings/0001104659-25-109155.md) | [965](/filings/0001821159-26-000019.md) | [920](/filings/0001821159-26-000010.md) | [967](/filings/0001821159-26-000019.md) |
| Current liabilities | $m | [92.3](/filings/0001558370-23-018279.md) | [89.3](/filings/0001558370-25-002400.md) | [81.6](/filings/0001558370-24-007044.md) | [90.1](/filings/0001558370-24-010606.md) | [102](/filings/0001558370-24-015319.md) | [111](/filings/0001104659-26-024827.md) | [111](/filings/0001558370-25-006523.md) | [118](/filings/0001558370-25-010333.md) | [133](/filings/0001104659-25-109155.md) | [135](/filings/0001821159-26-000019.md) | [116](/filings/0001821159-26-000010.md) | [125](/filings/0001821159-26-000019.md) |
| Total liabilities | $m | [249](/filings/0001558370-23-018279.md) | [266](/filings/0001558370-25-002400.md) | [270](/filings/0001558370-24-007044.md) | [292](/filings/0001558370-24-010606.md) | [326](/filings/0001558370-24-015319.md) | [360](/filings/0001104659-26-024827.md) | [433](/filings/0001558370-25-006523.md) | [464](/filings/0001558370-25-010333.md) | [543](/filings/0001104659-25-109155.md) | [579](/filings/0001821159-26-000019.md) | [568](/filings/0001821159-26-000010.md) | [657](/filings/0001821159-26-000019.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001104659-26-024827.md) | [76.3](/filings/0001558370-25-006523.md) | [96.5](/filings/0001558370-25-010333.md) | [156](/filings/0001104659-25-109155.md) | [204](/filings/0001821159-26-000019.md) | [209](/filings/0001821159-26-000010.md) | [294](/filings/0001821159-26-000019.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001104659-26-024827.md) | not reported | not reported | [1.2](/filings/0001104659-25-109155.md) | [2.1](/filings/0001821159-26-000019.md) | [2.8](/filings/0001821159-26-000010.md) | [3.6](/filings/0001821159-26-000019.md) |
| Shareholders' equity | $m | [(93.4)](/filings/0001558370-24-015319.md) | [(161)](/filings/0001104659-26-024827.md) | [25.7](/filings/0001104659-25-109155.md) | [13.6](/filings/0001104659-25-109155.md) | [(345)](/filings/0001104659-25-109155.md) | [(256)](/filings/0001821159-26-000019.md) | [(36.8)](/filings/0001821159-26-000019.md) | [(230)](/filings/0001821159-26-000019.md) | [(428)](/filings/0001104659-25-109155.md) | [(117)](/filings/0001821159-26-000019.md) | [38.7](/filings/0001821159-26-000019.md) | [(20.5)](/filings/0001821159-26-000019.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7.3) d](/filings/0001558370-24-015319.md) | [(7.3) d](/filings/0001558370-25-002400.md) | [(14.1)](/filings/0001558370-25-006523.md) | [7.6 d](/filings/0001558370-25-010333.md) | [12.1 d](/filings/0001104659-25-109155.md) | [(12.8) d](/filings/0001104659-26-024827.md) | [(10.2)](/filings/0001821159-26-000010.md) | [14.1 d](/filings/0001821159-26-000019.md) | [(22.8) d](/filings/0001104659-25-109155.md) | [11.3 d](/filings/0001104659-26-024827.md) | [(35.4)](/filings/0001821159-26-000010.md) | [(6.5) d](/filings/0001821159-26-000019.md) |
| Capital expenditure | $m | [24.0 d](/filings/0001558370-24-015319.md) | [34.8 d](/filings/0001558370-25-002400.md) | [21.1](/filings/0001558370-25-006523.md) | [24.2 d](/filings/0001558370-25-010333.md) | [25.8 d](/filings/0001104659-25-109155.md) | [23.7 d](/filings/0001104659-26-024827.md) | [15.0](/filings/0001821159-26-000010.md) | [26.2 d](/filings/0001821159-26-000019.md) | [26.2 d](/filings/0001104659-25-109155.md) | [49.4 d](/filings/0001104659-26-024827.md) | [30.6](/filings/0001821159-26-000010.md) | [33.8 d](/filings/0001821159-26-000019.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [69.3](/filings/0001821159-23-000007.md) | [68.6](/filings/0001558370-23-018279.md) | [71.0](/filings/0001558370-24-007044.md) | [85.3](/filings/0001558370-24-010606.md) | [103](/filings/0001558370-24-015319.md) | [105](/filings/0001558370-25-006523.md) | [106](/filings/0001558370-24-010606.md) | [106](/filings/0001558370-24-015319.md) | [132](/filings/0001821159-26-000010.md) | [133](/filings/0001821159-26-000019.md) | [138](/filings/0001821159-26-000010.md) | [140](/filings/0001821159-26-000019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.